Radiolabeled anti-prostate specific membrane antigen (PSMA) monoclonal antibody J591 (177Lu-J591) for nonmetastatic castration-resistant prostate cancer (CRPC): A randomized phase II trial

Authors

• William Kelly

Publication/Presentation Date

5-2011

Volume

29

Issue

15

Published In/Presented At

DOI: 10.1200/jco.2011.29.15_suppl.tps19

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

Department(s)

Administration and Leadership

Document Type

Article